BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16234103)

  • 1. [Study of biocompatibility of polybutylcyanoacrylate nanoparticles].
    Yang XX; Chen JH; Guo D
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1261-3. PubMed ID: 16234103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
    Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
    Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
    Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
    Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
    Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
    J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy.
    Zhang Y; Zhang Y; Chen J; Zhang B; Pan Y; Ren L; Zhao J; Luo Y; Zhai D; Wang S; Wang J
    Nanomedicine; 2007 Jun; 3(2):144-53. PubMed ID: 17468053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetic study on cytarabine nanoparticle lyophilization injection in rabbits].
    Zhou J; Jiang XH; He L; Li CR; Yang JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):145-7. PubMed ID: 16468665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-fungal efficacy of polybutylcyanoacrylate nanoparticles of allicin and comparison with pure allicin.
    Luo DQ; Guo JH; Wang FJ; Jin ZX; Cheng XL; Zhu JC; Peng CQ; Zhang C
    J Biomater Sci Polym Ed; 2009; 20(1):21-31. PubMed ID: 19105898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
    Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
    Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].
    Zhang ZR; Liao GT; Ye LM
    Yao Xue Xue Bao; 1995 Nov; 30(11):843-7. PubMed ID: 8712010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies on biocompatibility of heterogeneous demineralized bone matrix particles].
    Liang X; Yang Z; Xiang Z; Li X; Huang G; Zhi W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):76-81. PubMed ID: 19192885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA].
    Zhang YY; Fu CJ; Zhang ZZ
    Yao Xue Xue Bao; 2006 May; 41(5):446-51. PubMed ID: 16848322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of albendazole polybutycyanocrylate nanoparticles and study on its pharmaceutical properties and tissue distribution].
    Zhang XN; Zhang Q; Wen H; Wang GQ; Sun DJ
    Yao Xue Xue Bao; 2003 Jun; 38(6):462-6. PubMed ID: 14513810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
    Kuo YC; Su FL
    Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of magnetic mitomycin C nanoparticles on proliferation and apoptosis of L-02 cells in vitro].
    Ren F; Yang XX; Chen JH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1485-7. PubMed ID: 16354611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles].
    Chen RD; Ren F; Li GF; Liu SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
    Weyermann J; Lochmann D; Georgens C; Rais I; Kreuter J; Karas M; Wolkenhauer M; Zimmer A
    Eur J Pharm Biopharm; 2004 Jul; 58(1):25-35. PubMed ID: 15207534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.